Kahan Leong
21Patents
12h-index
9Co-inventors
70Inventor score
Filing activity: Jun 1, 1999 → Jun 13, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6329503A | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 91 | Expired |
| US7053186B2 | Antibodies immunospecific for STEAP1 | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7037667B1 | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer | Physics | 33 | Expired |
| US8414898B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 33 | Active |
| US6887975B2 | Peptides derived from STEAP1 | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7166714B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6943235B1 | Transmembrane protein expressed in prostate cancer | Chemistry; Metallurgy | 21 | Expired |
| US7575749B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7642054B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US7611904B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US7968307B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US7928201B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US6277972A | BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells | Chemistry; Metallurgy | 11 | Expired |
| US7306796B2 | 13-transmembrane protein expressed in prostate cancer | Chemistry; Metallurgy | 6 | Expired |
| US7227008B2 | 13-transmembrane protein expressed in prostate cancer | Chemistry; Metallurgy | 4 | Expired |
| US7220823B2 | Transmembrane protein expressed in prostate and other cancers | Chemistry; Metallurgy | 4 | Expired |
| US8383777B2 | 13-transmembrane protein expressed in prostate cancer | Chemistry; Metallurgy | 1 | Active |
| US7785811B2 | BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells | Chemistry; Metallurgy | 0 | Expired |
| US7981624B2 | Methods to detect tumors using 20P1F12/TMPRSS2 expression | Physics | 0 | Active |
| US8003758B2 | BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells | Chemistry; Metallurgy | 0 | Active |
| US7858760B2 | Antibodies to protein expressed in prostate cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.